newsfilter
← Latest News
GlobeNewswire·

Vigil Neuroscience Appoints Samantha Budd Haeberlein, Ph.D. to Board of Directors

WATERTOWN, Mass., May 09, 2023 (GLOBE NEWSWIRE) -- Vigil Neuroscience, Inc. (NASDAQ:VIGL), a clinical-stage biotechnology company committed to harnessing the power of microglia for the treatment of neurodegenerative